Your Premier Destination for High-Quality Aesthetic Products and Transformative Beauty Solutions
Laennec Side Effects: What Practitioners Should Know Before Adding It to Their Menu
Written by FillersFairy Editorial · Reviewed by FillersFairy Clinical Team · Last updated: June 23, 2026
Quick Answer
Laennec has over 50 years of continuous clinical use with a well-established safety profile. The most commonly reported side effects are mild injection site reactions — redness, swelling or tenderness — that typically resolve within 24–48 hours without intervention. As a pharmaceutical-grade product manufactured under Japanese GMP by Japan Bio Products (JBP), Laennec undergoes rigorous safety screening including donor testing and pathogen inactivation. Most side effects are technique-related (injection site, speed, volume) rather than product-related, making them preventable through proper administration.
Why Laennec’s Safety Profile Is Reassuring
When evaluating any injectable product, the first question practitioners ask is: what’s the safety track record? Laennec’s answer is stronger than almost any product in the aesthetic space:
50+ years of continuous clinical use. JBP has manufactured Laennec since 1970. Over five decades of post-market surveillance provides a safety dataset that newer products simply cannot match.
Pharmaceutical classification. In Japan, Laennec is classified as an ethical drug — the most regulated product category. This means ongoing safety monitoring, adverse event reporting requirements and manufacturing quality surveillance.
Specific biological product designation. Laennec carries Japan’s highest traceability classification for biological products, requiring 20-year record preservation of every patient administration. This level of traceability exists specifically because safety matters.
Rigorous donor screening. All placental tissue undergoes screening for infectious diseases before entering the manufacturing process. JBP’s pathogen inactivation protocols have evolved with advances in virology over the product’s 50+ year history.
Common Side Effects (Mild and Temporary)
The vast majority of reported Laennec side effects fall into the “expected and manageable” category — reactions that occur at the injection site and resolve quickly without treatment:
| Side Effect | Frequency | Duration | What to Tell the Patient |
|---|---|---|---|
| Injection site redness | Common | Hours to 24h | Normal reaction. Will fade on its own. No treatment needed. |
| Mild swelling at injection site | Common | 12–48h | The body is processing the placenta extract. Cold compress can help if needed. |
| Injection site tenderness | Common | 24–48h | Mild soreness similar to any subcutaneous injection. Resolves without treatment. |
| Mild bruising | Occasional | 3–7 days | Needle-related, not product-related. More common in patients on blood thinners. |
| Temporary warmth or flushing | Occasional | Minutes to hours | Biological response to growth factors. Indicates the product is active. Resolves quickly. |
Key point for clinic buyers: These side effects are comparable to — or milder than — those seen with HA skin boosters, PN injections and other mesotherapy treatments. They are technique-related (injection site, needle gauge, injection speed) rather than product-specific, and are manageable through proper administration.
Rare Side Effects
As with any injectable biological product, rare adverse reactions are possible:
Allergic reaction. As Laennec contains biological substances from human placental tissue, allergic reactions are possible in sensitive individuals. Practitioners should take a thorough medical history and be aware of any known allergies before administration.
Transient fever or malaise. A small number of patients may experience mild systemic symptoms (slight temperature elevation, tiredness) for 24–48 hours after treatment. This represents a normal immune response to biological growth factors and typically resolves without intervention.
Injection site induration. Rarely, a small firm area may develop at the injection site. This is typically self-resolving over several days. Proper injection technique (appropriate depth, volume distribution) minimises this risk.
Prevention: What Practitioners Can Control
The most effective approach to Laennec side effects is prevention through proper technique. Most reported reactions are technique-related — meaning they are within the practitioner’s control:
Injection speed. Slow, steady injection reduces tissue trauma and minimises pain and swelling. Rushing the injection is the most common cause of unnecessary discomfort.
Volume distribution. Distributing the injection volume across multiple sites (rather than injecting the full ampoule in one location) reduces localised swelling and allows more even absorption.
Needle selection. Using an appropriate gauge needle (typically 27G–30G for subcutaneous administration) balances injection comfort with product flow.
Patient screening. Reviewing the patient’s medical history for allergies, autoimmune conditions, pregnancy, breastfeeding, and current medications before the first treatment. Patients on anticoagulants are more prone to bruising.
Product authentication. Ensuring the product is sourced from verified channels with intact packaging, correct lot numbers and valid expiry dates. Quality-related side effects are eliminated when the product is genuine and properly stored.
Patient Communication Guide
How you communicate about side effects directly affects patient confidence and satisfaction. The most effective framework for Laennec:
“Laennec has been used clinically for over 50 years. The most common reactions are mild redness or tenderness at the injection site, which typically resolve within a day or two. These are normal responses — they indicate that the growth factors are being processed by your body. If you experience any unusual or persistent symptoms, contact the clinic.”
This framing accomplishes three things: it establishes the product’s track record (50 years), normalises mild reactions (expected, not concerning), and provides a clear safety net (contact the clinic for anything unusual).
Practitioner Confidence Summary
Laennec’s side effect profile is mild, predictable and manageable — comparable to or better than most injectable aesthetic treatments. The 50-year safety track record, pharmaceutical-grade manufacturing under Japanese GMP and biological product traceability requirements make it one of the best-documented injectable products in clinical use. For practitioners, the key is proper technique (injection speed, volume distribution, needle selection) and patient communication. Side effects are rarely a barrier to treatment — most patients tolerate Laennec well and return for subsequent sessions without hesitation. View Laennec product details →
Frequently Asked Questions
Is Laennec injection safe?
Laennec has over 50 years of continuous clinical use in Japan, manufactured under Japanese GMP standards by Japan Bio Products. It carries Japan’s highest traceability classification for biological products, requiring 20-year record preservation. Common side effects are mild injection site reactions that resolve within 24–48 hours.
What are the most common Laennec side effects?
Injection site redness, mild swelling and tenderness — all of which typically resolve within 24–48 hours without treatment. These are comparable to side effects seen with other injectable treatments like HA skin boosters and PN therapy.
Does Laennec cause allergic reactions?
Allergic reactions are possible but rare. Laennec contains biological substances from human placental tissue, so practitioners should screen patients for allergies before the first treatment. A thorough medical history review is standard practice.
How long do Laennec side effects last?
Most side effects resolve within 24–48 hours. Bruising (if it occurs) may take 3–7 days. Transient systemic symptoms like mild fever are uncommon and resolve within 24 hours. Persistent or unusual symptoms should be reported to the treating practitioner.
Can I reduce Laennec side effects?
Yes. Most side effects are technique-related and preventable. Slow injection speed, proper volume distribution across multiple sites, appropriate needle gauge and correct storage all minimise reactions. Patient screening for allergies and contraindications before the first session is essential.
Related Guides
Disclosure: FillersFairy is a wholesale supplier of Laennec and other aesthetic products. This article is for educational purposes only and does not constitute medical advice. Laennec is a prescription pharmaceutical — regulatory status and availability vary by country.
References
- Japan Bio Products Co., Ltd. LAENNEC official product information and safety data. jbpglobal.placenta.co.jp.
- JBP designation as specific biological product — 20-year record preservation requirement. Japanese pharmaceutical regulation.
Recommended Products
JBP Nano
Price range: $85.00 through $98.00
This product has multiple variants. The options may be chosen on the product page
